Citations

Showing 10 of 108094 citations.

The clinical implication of monoclonal gammopathies: monoclonal gammopathy of undetermined significance and of renal significance
Batko, Krzysztof , Małyszko, Jolanta , Jurczyszyn, Artur, Vesole, David H, Gertz, Morie A, Leleu, Xavier, Suska, Anna , Krzanowski, Marcin, Sułowicz, Władysław, Małyszko, Jacek , Krzanowska, Katarzyna , Vesole, David H. , Gertz, Morie A. , Krzanowski, Marcin

Mayo Clinic

Nephrology Dialysis Transplantation | July 16, 2018 | Volume: 34 | Issue: 9 | Pages: 1440-1452

10.1093/ndt/gfy259 | PMID 30169860 Get It

AbstractMonoclonal gammopathy of renal significance (MGRS) has introduced a new perspective to several well-known disease entities impacting nephrology, haematology and pathology. Given the constantly changing disease spectrum of these entities, it is clinically imperative to establish diagnostic and treatment pathways supported by evidence-based medicine. MGRS is a disease of the kidney, secondary to plasma cell clonal proliferation or immune dysfunction, requiring therapeutic intervention to eradicate the offending clone. To fully understand the disease(s), it is prerequisite to determine the significance of the findings. The diagnostic work up should be extensive due to the wide heterogeneity of clinical presentation, ultimately necessitating kidney biopsy. Particular patient profiles such as AL amyloidosis, which may be diagnosed through biopsies of other tissues/organs, may be an exception. Treatment decisions should be formulated by multi-disciplinary consensus: nephrologists, haematologists and pathologists. The ultimate goal in managing MGRS is eradication of the offending plasma cell clone which requires targeted chemotherapy and, in eligible cases, haematopoietic stem cell transplantation. We present a review of diagnostic procedures, treatment options and advances in the last few years in the management of MGRS in an effort to acquaint specialists with this new face of several older diseases.
Monoclonal gammopathy of clinical significance: a novel concept with therapeutic implications
Fermand, Jean-Paul, Bridoux, Frank , Jaccard, Arnaud , Kyle, Robert A. , Leung, Nelson , Merlini, Giampaolo , Dispenzieri, Angela , Jaccard, Arnaud , Kyle, Robert A , Leung, Nelson , Merlini, Giampaolo , Fermand, Jean‐Paul , Dispenzieri, Angela

Mayo Clinic

Blood | July 16, 2018 | Volume: 132 | Issue: 14 | Pages: 1478-1485

10.1182/blood-2018-04-839480 | PMID 30012636 Get It

Abstract Monoclonal gammopathy is a common condition, particularly in the elderly. It can indicate symptomatic multiple myeloma or another overt malignant lymphoid disorder requiring immediate chemotherapy. More frequently, it results from a small and/or quiescent secreting B-cell clone, is completely asymptomatic, and requires regular monitoring only, defining a monoclonal gammopathy of unknown significance (MGUS). Sometimes, although quiescent and not requiring any treatment per se, the clone is associated with potentially severe organ damage due to the toxicity of the monoclonal immunoglobulin or to other mechanisms. The latter situation is increasingly observed but still poorly recognized and frequently undertreated, although it often requires rapid specific intervention to preserve involved organ function. To improve early recognition and management of these small B-cell clone–related disorders, we propose to introduce the concept of monoclonal gammopathy of clinical significance (MGCS). This report identifies the spectrum of MGCSs that are classified according to mechanisms of tissue injury. It highlights the diversity of these disorders for which diagnosis and treatment are often challenging in clinical practice and require a multidisciplinary approach. Principles of management, including main diagnostic and therapeutic procedures, are also described. Importantly, efficient control of the underlying B-cell clone usually results in organ improvement. Currently, it relies mainly on chemotherapy and other anti–B-cell/plasma cell agents, which should aim at rapidly producing the best hematological response.
Linking Cigarette Smoking/Tobacco Exposure and Cluster Headache: A Pathogenesis Theory
Rozen, Todd D.

Mayo Clinic

Headache: The Journal of Head and Face Pain | July 16, 2018 | Volume: 58 | Issue: 7 | Pages: 1096-1112

10.1111/head.13338 | PMID 30011061 Get It

Introduction To propose a hypothesis theory to establish a linkage between cigarette smoking and cluster headache pathogenesis. Background Cluster headache is a primary headache syndrome grouped under the trigeminal autonomic cephalalgias. What distinguishes cluster headache from all other primary headache conditions is its inherent connection to cigarette smoking. It is undeniable that tobacco exposure is in some manner related to cluster headache. The connection to tobacco exposure for cluster headache is so strong that even if an individual sufferer never smoked, then that individual typically had significant secondary smoke exposure as a child from parental smoking behavior and in many instances both scenarios exist. The manner by which cigarette smoking is connected to cluster headache pathogenesis is unknown at present. If this could be determined this may contribute to advancing our understanding of cluster headache pathophysiology. Methods/results Hypothesis statement. Conclusion The hypothesis theory will include several principles: (1) the need of double lifetime tobacco exposure, (2) that cadmium is possibly the primary agent in cigarette smoke that leads to hypothalamic‐pituitary‐gonadal axis toxicity promoting cluster headache, (3) that the estrogenization of the brain and its specific sexually dimorphic nuclei is necessary to develop cluster headache with tobacco exposure, and (4) that the chronic effects of smoking and its toxic metabolites including cadmium and nicotine on the cortex are contributing to the morphometric and orexin alterations that have been previously attributed to the primary headache disorder itself.
DRESS Following FIRES: A Clinical Conundrum
Dahl, Amanda , Knoebel, Erin E., Lloyd, Robin M. , Dahl, Amanda R

Mayo Clinic

Clinical Pediatrics | July 16, 2018 | Volume: 57 | Issue: 12 | Pages: 1479-1482

10.1177/0009922818787321 | PMID 30010401 Get It

Year in Review in Cardiac Electrophysiology
Park, David , Viswanathan, Mohan , Madhavan, Malini , Ceresnak, Scott R. , Wang, Paul J. , Kapa, Suraj , Park, David S , Davis, Darryl Raymond , Steinberg, Benjamin A. , Tzou, Wendy S.

Mayo Clinic

Circulation: Arrhythmia and Electrophysiology | July 16, 2018 | Volume: 11 | Issue: 7 | Pages: No page available

10.1161/circep.118.006648 | PMID 30012874 Get It

Prediction Models for Clinical Outcome After a Carotid Revascularization Procedure
Volkers, Eline J., Kappelle, L. Jaap, Jansen, Olav , Howard, George , Hendrikse, Jeroen , Gregson, John , Fraedrich, Gustav , Calvet, David, Bulbulia, Richard , Brown, Martin M. , Becquemin, Jean‐Pierre , Mas, Jean‐Louis , Bonati, Leo H. , Brott, Thomas G. , Greving, Jacoba P. , Howard, George , Algra, Ale , Halliday, Alison , Eckstein, Hans‐Henning , Ringleb, Peter Arthur

Mayo Clinic

Stroke | July 16, 2018 | Volume: 49 | Issue: 8 | Pages: 1880-1885

10.1161/strokeaha.117.020486 | PMID 30012816 Get It

Background and Purpose— Prediction models may help physicians to stratify patients with high and low risk for periprocedural complications or long-term stroke risk after carotid artery stenting or carotid endarterectomy. We aimed to evaluate external performance of previously published prediction models for short- and long-term outcome after carotid revascularization in patients with symptomatic carotid artery stenosis. Methods— From a literature review, we selected all prediction models that used only readily available patient characteristics known before procedure initiation. Follow-up data from 2184 carotid artery stenting and 2261 carotid endarterectomy patients from 4 randomized trials (EVA-3S [Endarterectomy Versus Angioplasty in Patients With Symptomatic Severe Carotid Stenosis], SPACE [Stent-Protected Angioplasty Versus Carotid Endarterectomy], ICSS [International Carotid Stenting Study], and CREST [Carotid Revascularization Endarterectomy Versus Stenting Trial]) were used to validate 23 short-term outcome models to estimate stroke or death risk ≤30 days after the procedure and the original outcome measure for which the model was developed. Additionally, we validated 7 long-term outcome models for the original outcome measure. Predictive performance of the models was assessed with C statistics and calibration plots. Results— Stroke or death ≤30 days after the procedure occurred in 158 (7.2%) patients after carotid artery stenting and in 84 (3.7%) patients after carotid endarterectomy. Most models for short-term outcome after carotid artery stenting (n=4) or carotid endarterectomy (n=19) had poor discriminative performance (C statistics ranging from 0.49–0.64) and poor calibration with small absolute risk differences between the lowest and highest risk groups and overestimation of risk in the highest risk groups. Long-term outcome models (n=7) had a slightly better performance with C statistics ranging from 0.59 to 0.67 and reasonable calibration. Conclusions— Current models did not reliably predict outcome after carotid revascularization in a trial population of patients with symptomatic carotid stenosis. In particular, prediction of short-term outcome seemed to be difficult. Further external validation of existing prediction models or development of new prediction models is needed before such models can be used to support treatment decisions in individual patients.
A Langendorff-like system to quantify cardiac pump function in adult zebrafish
Dvornikov, Alexey V. , Huttner, Inken G., Ma, Xiao , Santiago, Celine , Xu, Xiaolei , Dvornikov, Alexey V , Lin, Xueying , Zhang, Hong , Fatkin, Diane

Mayo Clinic

Disease Models & Mechanisms | July 16, 2018 | Volume: 11 | Issue: 9 | Pages: No page available

10.1242/dmm.034819 | PMID 30012855 Get It

ABSTRACT Zebrafish are increasingly used as a vertebrate model to study human cardiovascular disorders. Although heart structure and function are readily visualized in zebrafish embryos because of their optical transparency, the lack of effective tools for evaluating the hearts of older, nontransparent fish has been a major limiting factor. The recent development of high-frequency echocardiography has been an important advance for in vivo cardiac assessment, but it necessitates anesthesia and has limited ability to study acute interventions. We report the development of an alternative experimental ex vivo technique for quantifying heart size and function that resembles the Langendorff heart preparations that have been widely used in mammalian models. Dissected adult zebrafish hearts were perfused with a calcium-containing buffer, and a beat frequency was maintained with electrical stimulation. The impact of pacing frequency, flow rate and perfusate calcium concentration on ventricular performance (including end-diastolic and end-systolic volumes, ejection fraction, radial strain, and maximal velocities of shortening and relaxation) were evaluated and optimal conditions defined. We determined the effects of age on heart function in wild-type male and female zebrafish, and successfully detected hypercontractile and hypocontractile responses after adrenergic stimulation or doxorubicin treatment, respectively. Good correlations were found between indices of cardiac contractility obtained with high-frequency echocardiography and with the ex vivo technique in a subset of fish studied with both methods. The ex vivo beating heart preparation is a valuable addition to the cardiac function tool kit that will expand the use of adult zebrafish for cardiovascular research.
Early Versus Late Motion Following Volar Plating of Distal Radius Fractures
Dennison, David G., Blanchard, Charlene L., Elhassan, Bassem T. , Moran, Steven L. , Elhassan, Bassem, Blanchard, Charlene L, Elhassan, Bassem T. , Shin, Alexander Y.

Mayo Clinic

HAND | July 16, 2018 | Volume: 15 | Issue: 1 | Pages: 125-130

10.1177/1558944718787880 | PMID 30009627 Get It

Background: Distal radius fractures are common, and the trend in fixation has included the use of locked volar plating. The duration of splinting required after surgery and the effect splinting has upon outcome of the wrist are not clear. Our aim was to compare outcome of patients treated with early versus late motion protocol after volar plating. Methods: Thirty-three patients with distal radius fractures were prospectively and randomly enrolled into an early versus late motion study including volar plating of the distal radius fracture. Early motion included an active and passive wrist motion protocol by 14 days after surgery and delayed motion was initiated at 5 weeks. Fractures were defined as intra-articular and extra-articular, and those with, and without, ulnar styloid fracture. Motion and outcome scores (Disabilities of the Arm, Shoulder and Hand [DASH]/patient-rated wrist evaluation [PRWE]), and strength were measured through 1 year. Results: Wrist motion, DASH, and PRWE scores were only significantly different at 6 weeks with no significant differences at any later time points up to 1 year. One patient had complex regional pain syndrome (CRPS) and one had adhesive capsulitis in the late motion group. Conclusions: Following locked volar plating of distal radius fractures, early motion favored earlier return of motion along with lower DASH, PRWE, and pain scores within first 6 weeks. Although the late motion group had delayed recovery, there were no long-term significant differences in motion, strength, outcome, or pain scores. The 2 cases with complications (CRPS and adhesive capsulitis) did occur in the late motion group and may implicate late motion with these problems.
Serotonin Syndrome in the Perioperative Setting
Pollard, E. Morgan, Nookala, Asha U., Olatoye, Oludare, Smischney, Nathan J. , Pollard, Emily M

Mayo Clinic

American Journal of Case Reports | July 16, 2018 | Volume: 19 | Issue: No issue available | Pages: 833-835

10.12659/ajcr.909497 | PMID 30008467 Get It